Ajanta Pharma has reported results for fourth quarter ended March 31, 2012.
On the standalone basis, the company has posted a rise of 35.11% in its net profit at Rs 23.59 crore for the quarter ended March 31, 2012 as compared to Rs 17.46 crore for the same quarter in the previous year. Total income has increased by 39.83% at Rs 176.10 crore for quarter under review as compared to Rs 125.94 crore for the quarter ended March 31, 2011.
For the full year ended March 31, 2012, on the consolidated basis, the company has posted a rise of 52.36% in its net profit at Rs 77.26 crore for the year ended March 31, 2012 as compared to Rs 50.71 crore for the same period in the previous year. Total income has increased by 35.80% at Rs 677.39 crore for year under review as compared to Rs 498.82 crore for the period ended March 31, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.00 |
Dr. Reddys Lab | 5780.70 |
Cipla | 1442.00 |
Zydus Lifesciences | 1088.45 |
Lupin | 1683.50 |
View more.. |